Saturday, July 4, 2026

MODERN-DAY COLONIALISM: Trump’s Merciless Plot To Steal Greenland For Minerals And War

Experts urge South Korea to enhance Arctic capabilities amid U.S. plans for Greenland annexation and growing China-Russia influence.

Unlocking Future Healthcare: Insights from the 2026 Data Economy Conference

Sogang University hosts the 7th Data Economy Conference to explore AI in healthcare and strategies for technology commercialization.

Why SKS is Outpacing Whirlpool: A Deep Dive into the 200K USD Luxury Home Appliance Market

LG Electronics' SKS appliances dominate the luxury market, with buyers paying $20,000 more for premium features and design.

Tag: Cenobamate

How SK Life Science is Bridging Communication Gaps in Epilepsy Management

SK Life Science will present findings on epilepsy treatment and patient-provider communication at the 2026 AAN Annual Meeting in Chicago.

Exploring Cenobamate: How SK Biopharmaceuticals’ New Oral Suspension Benefits Adult Epilepsy Patients

SK Biopharmaceuticals submits NDA for Cenobamate oral suspension, enhancing treatment options for epilepsy patients with swallowing difficulties.

SK Biopharm Launches New Innovative Epilepsy Treatment Drug, Cenobamate, in China

SK Biopharm's epilepsy drug Cenobamate launches in China, marking a key milestone in its global expansion and commercialization strategy.

SK Biopharm’s 2026 Sales Meeting: Key Strategies for Senolamate’s Global Success

SK Biopharm's U.S. subsidiary held its annual sales meeting, focusing on growth strategies and collaboration for Cenobamate's success.

Top News

- Our Sponsors Ad -

Follow us